Rapid and slow response during treatment of generalized anxiety disorder with peptide anxiolytic selank
European Psychiatry
Bibliographic match not independently verified. Not used as support for clinical benefit.
Synthetic tuftsin-related heptapeptide
Also indexed as: Tuftsin analog
The supplied conference-style citation could not be independently verified. Independent replication and broadly applicable clinical outcome evidence are limited.
Unfamiliar word? Open this panel for simple explanations, right here.
6 glossary terms used in this profile
Select a word to see its meaning. You can keep more than one definition open.
Definitions explain the words—not whether a molecule works or is safe. Research education only, not medical advice.
Selank is a synthetic heptapeptide related to tuftsin. It is discussed in anxiety-related and neuropeptide research, but this edition could not independently match the supplied clinical citation.
Tuftsin-related / neuropeptide signaling
Research proposes effects on neuropeptide and inhibitory signaling, including GABA-related pathways. A definitive mechanism for broadly reproducible human clinical benefit is not established.
A biological pathway describes a proposed or observed interaction—not necessarily a demonstrated health outcome.
Decode the terminology in our glossaryNot enough reliable evidence
There is too little dependable or verified research here to draw a useful conclusion about benefit in people.
For this research: The supplied conference-style citation could not be independently verified. Independent replication and broadly applicable clinical outcome evidence are limited.
An editorial guide—not a validated score, a percentage, a safety rating or an approval badge. Regulatory status is separate. More research does not mean fewer risks.
Mechanistic laboratory evidence is not separately assessed in this selected-source summary; see references and their study types.
Animal evidence is not separately assessed here. Findings in animals must not be interpreted as demonstrated human benefit.
Associations, biomarker studies and anecdotes cannot establish treatment causality; no observational result is used here to infer clinical effectiveness.
Reliable, independently replicated human outcome evidence is not established by the selected sources in this edition.
No FDA-approved finished drug for this molecule is identified in this edition. Investigational use, published research or compounding does not establish FDA approval.
Anxiety-related signaling and neurobehavioral hypotheses.
These describe scientific questions, not prescribing recommendations. A research grouping does not establish combination safety or clinical effectiveness.
Explore research by health goalFDA identifies insufficient safety information and possible immunogenicity and impurities. Interactions with psychiatric and sedative medicines are poorly characterized.
This is not an exhaustive safety or contraindication list. An absence of reported harm is not proof of safety. Pregnancy, breastfeeding, cancer history, endocrine disease and concurrent medicines can materially change risk. Unregulated preparations add identity, contamination and sterility risks.
Read FDA’s compounding safety informationNot FDA-approved
No FDA-approved finished drug for this molecule is identified in this edition. Investigational use, published research or compounding does not establish FDA approval.
Regulatory status and evidence strength are different. A nomination for compounding, a clinical-trial registration or a “research use only” label is not approval. International rules vary; consult the current regulator and product label.
Rapid and slow response during treatment of generalized anxiety disorder with peptide anxiolytic selank
European Psychiatry
Bibliographic match not independently verified. Not used as support for clinical benefit.
Matched bibliographic records confirm a publication’s identity, not the validity of every claim. Selected sources are not a systematic literature review.
These open search results, not additional verified citations. Trial registration is not evidence that a treatment works.
Beyond the library
Explore our broader health optimization approach. A library entry does not mean a molecule is offered, prescribed, or appropriate for you.
Continue to our existing activation & intake page.
Education, not a prescription. Research summaries are not medical advice, dosing instructions, or an offer to sell. Mechanistic findings do not establish clinical effectiveness. US regulatory status is product- and indication-specific and may change. Discuss health decisions with a licensed clinician.